Exploration of peptide motifs for potent non-viral gene delivery highly selective for dividing cells

Journal of Gene Medicine

Volumn 7, Issue 12, 2005, Pages 1545-1554

  Parker, Alan L ^a   Collins, Louise ^a   Zhang, Xiaohong ^a   Fabre, John W ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Fusogenic peptide; Gene therapy; Mitosis; Non viral gene delivery; Nuclear translocation; Oligolysine

Indexed keywords

ADENOVIRUS VECTOR; HEMOGLOBIN; LIPOFECTAMINE; LYSINE; NANOPARTICLE; POLYETHYLENEIMINE; SYNTHETIC PEPTIDE; VIRUS DNA; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIVISION; CELL STRAIN HEPG2; CELL VIABILITY; CIRCULAR DICHROISM; CONTROLLED STUDY; CORNEA ENDOTHELIUM; ENDOCYTOSIS; ENDOTHELIUM CELL; ERYTHROCYTE; GEL ELECTROPHORESIS; GENE TRANSLOCATION; GENETIC TRANSFECTION; GROWTH INHIBITION; HELA CELL; HUMAN; HUMAN CELL; INFLUENZA VIRUS; LIGHT SCATTERING; MITOSIS; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PARTICLE SIZE; PLASMID; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN MOTIF; RABBIT; RAT; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; AMINO ACID MOTIFS; ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; CELL SURVIVAL; CIRCULAR DICHROISM; ELECTROPHORESIS, AGAR GEL; ENDOTHELIUM, CORNEAL; GENE THERAPY; GENETIC VECTORS; HUMANS; LIPIDS; LUCIFERASES; NANOSTRUCTURES; PARTICLE SIZE; PEPTIDES; PLASMIDS; POLYETHYLENEIMINE; PROTEIN CONFORMATION; RABBITS; TRANSFECTION;

ADENOVIRIDAE; ANIMALIA; DNA VIRUSES; HUMAN INFLUENZA VIRUS; ORTHOMYXOVIRIDAE; ORYCTOLAGUS CUNICULUS;

EID: 29744464073     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.809     Document Type: Article

References (37)

1. Muruve DA, Barnes MJ, Stillman IE, Libermann TA. Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo. Hum Gene Ther 1999; 10: 965-976.
2. Editorial. Gene therapy - a loss of innocence. Nat Med 2000; 6: 1.
3. Smith AE, Helenius A. How viruses enter animal cells. Science 2004; 304: 237-242.
4. Conner SD, Schmid SL. Regulated portals of entry into the cell. Nature 2003; 422: 37-44.
5. Lear JD, DeGrado WF. Membrane binding and conformational properties of peptides representing the NH2 terminus of influenza HA-2. J Biol Chem 1987; 262: 6500-6505.
6. Wagner E, Plank C, Zatloukal Y, Cotten M, Birnstiel ML. Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle. Proc Natl Acad Sci U S A 1992; 89: 7934-7938.
7. Plank C, Oberhauser B. Mechtler Y, Koch C. Wagner E. The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. J Biol Chem 1994; 269: 12 918-12 924.
8. Gottschalk S, Sparrow JT, Hauer J, et al. A novel DNA-peptide complex for efficient gene transfer and expression in mammalian cells. Gene Ther 1996; 3: 48-57.
9. Wilke M, Fortunati E, van den BM, Hoogeveen AT, Scholte BJ. Efficacy of a peptide-based gene delivery system depends on mitotic activity. Gene Ther 1996; 3: 1133-1142.
10. Kichler A, Freulon I, Boutin V, Mayer R, Monsigny M, Midoux P. Glycofection in the presence of anionic fusogenic peptides: a study of the parameters affecting the peptide-mediated enhancement of the transfection efficiency. J Gene Med 1999; 1: 134-143.
11. de Lima MC, Simoes S, Pires P, Gaspar R, Slepushkin V, Duzgunes N. Gene delivery mediated by cationic liposomes: from biophysical aspects to enhancement of transfection. Mol Membr Biol 1999; 16: 103-109.
12. Zhang X, Collins L, Fabre JW. A powerful cooperative interaction between a fusogenic peptide and lipofectamine for the enhancement of receptor-targeted, non-viral gene delivery via integrin receptors. J Gene Med 2001; 3: 560-568.
13. Collins L, Fabre JW. A synthetic peptide vector system for optimal gene delivery to corneal endothelium. J Gene Med 2004; 6: 185-194.
14. Shewring L, Collins L, Lightman SL, Hart S, Gustafsson K, Fabre JW. A nonviral vector system for efficient gene transfer to corneal endothelial cells via membrane integrins. Transplantation 1997; 64: 763-769.
15. Hart SL, Collins L, Gustafsson Y, Fabre JW. Integrin-mediated transfection with peptides containing arginine-glycine-aspartic acid domains. Gene Ther 1997; 4: 1225-1230.
16. Collins L, Gustafsson Y, Fabre JW. Tissue-binding properties of a synthetic peptide DNA vector targeted to cell membrane integrins: a possible universal nonviral vector for organ and tissue transplantation. Transplantation 2000; 69: 1041-1050.
17. Collins L, Sawyer GJ, Zhang XH, Gustafsson K, Fabre JW. In vitro investigation of factors important for the delivery of an integrin-targeted nonviral DNA vector in organ transplantation. Transplantation 2000; 69: 1168-1176.
18. Li JM, Collins L, Zhang X, Gustafsson Y, Fabre JW. Efficient gene delivery to vascular smooth muscle cells using a nontoxic, synthetic peptide vector system targeted to membrane integrins: a first step toward the gene therapy of chronic rejection. Transplantation 2000; 70: 1616-1624.
19. Patel S, Zhang X. Collins L, Fabre JW. A small, synthetic peptide for gene delivery via the serpin-enzyme complex receptor. J Gene Med 2001; 3: 271-279.
20. Zhang X, Collins L, Sawyer GJ, Dong X, Qiu Y, Fabre JW. In vivo gene delivery via portal vein and bile duct to individual lobes of the rat liver using a polylysine-based nonviral DNA vector in combination with chloroquine. Hum Gene Ther 2001; 12: 2179-2190.
21. Zhang X, Sawyer GJ, Dong X, Qiu Y, Collins L, Fabre JW. The in vivo use of chloroquine to promote non-viral gene delivery to the liver via the portal vein and bile duct. J Gene Med 2003; 5: 209-218.
22. Collins L, Asuni AA, Anderton BH, Fabre JW. Efficient gene delivery to primary neuron cultures using a synthetic peptide vector system. J Neurosci Methods 2003; 125: 113-120.
23. Collins L, Kaszuba M, Fabre JW. Imaging in solution of (Lys)(16)-containing bifunctional synthetic peptide/DNA nanoparticles for gene delivery. Biochim Biophys Acta 2004; 1672: 12-20.
24. Colin M, Moritz S, Fontanges P, et al. The nuclear pore complex is involved in nuclear transfer of plasmid DNA condensed with an oligolysine-RGD peptide containing nuclear localisation properties. Gene Ther 2001; 8: 1643-1653.
25. Kalderon D, Roberts BL, Richardson WD, Smith AE. A short amino acid sequence able to specify nuclear location. Cell 1984; 39: 499-509.
26. Scopes RK. Measurement of protein by spectrophotometry at 205 nm. Anal Biochem 1974; 59: 277-282.
27. Gratzer WB, Beaven GH. Optical spectroscopy in techniques in the life sciences. In Protein and Enzyme Biochemistry, Elsevier: Amsterdam, 1984; 1-47.
28. Harper JV. Synchronization of cell populations in G1/S and G2/M phases of the cell cycle. Methods Mol Biol 2005; 296: 157-166.
29. Mortimer I, Tam P, MacLachlan I, Graham RW, Saravolac EG, Joshi PB. Cationic lipid-mediated transfection of cells in culture requires mitotic activity. Gene Ther 1999; 6: 403-411.
30. Brunner S, Sauer T, Carotta S, Cotten M, Saltik M, Wagner E. Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus. Gene Ther 2000; 7: 401-407.
31. Rainov NG, Ren H. Clinical trials with retrovirus mediated gene therapy - what have we learned? J Neurooncol 2003; 65: 227-236.
32. Caplen NJ. Gene therapy progress and prospects. Downregulating gene expression: the impact of RNA interference. Gene Ther 2004; 11: 1241-1248.
33. Deng H, Wolff JA. Self-amplifying expression from the T7 promoter in 3T3 mouse fibroblasts. Gene 1994; 143: 245-249.
34. Parker AL, Oupicky D, Dash PP, Seymour LW. Methodologies for monitoring nanoparticle formation by self-assembly of DNA with poly(l-lysine). Anal Biochem 2002; 302: 75-80.
35. Carr CM, Kim PS. A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell 1993; 73: 823-832.
36. Parker KE, Dalchau R, Fowler VJ, Priestley CA, Carter CA, Fabre JW. Stimulation of CD+ T lymphocytes by allogenic MHC peptides presented on autologous antigen-presenting cells. Transplantation 1992; 53: 918-924.
37. Scarborough RM, Rose JW, Naughton MA, et al. Characterization of the integrin specificities of disintegrins isolated from American pit viper venoms. J Biol Chem 1993; 268: 1058-1065.